Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qihong capsule for chronic heart failure (Qi deficiency and blood stasis) – Phase 2
ChiCTR2100052399Phase 2Not yet recruiting
- Sponsor
- Traditional Chinese Medicine Hospital Affiliated to Xinjiang Medical University
- Start
- Nov 2021
- Countries
- 1
01
Overview
Phase 2, randomised trial of 芪红胶囊 in chronic heart failure (CHF) (2 arms), sponsored by Traditional Chinese Medicine Hospital Affiliated to Xinjiang Medical University. Primary endpoints: N-terminal pro–brain natriuretic peptide (NT-proBNP) and 6-minute walk test. Planned start Nov 2021; status: not yet recruiting.
02
Drugs
芪红胶囊
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on ChiCTR2100052399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100052399.